Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REMIMAZOLAM vs REPAGLINIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REMIMAZOLAM vs REPAGLINIDE: Safety Overview

Metric REMIMAZOLAM REPAGLINIDE
Total FAERS Reports 137 2,544
Deaths Reported 3 169
Death Rate 2.2% 6.6%
Hospitalizations 24 1,517
Average Patient Age 60.4 yrs 71.9 yrs
% Female Patients 41.5% 45.5%
FDA Approval Date Oct 6, 2020 Apr 24, 2015
Manufacturer Acacia Pharma, Ltd. Rising Pharma Holdings, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued